TrialESC heart failure2026

Effect of anti-fibrotic therapy on regression of myocardial fibrosis after TAVI: design and rationale of the Reduce-MFA DZHK25 trial.

Miriam Puls et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.